Normal mouse sera contain naturally occurring antibodies that are cytotoxic in the presence of rabbit complement for NBI, a cell line derived from a neuroblastoma adrenal metastasis of a spontaneous ovarian teratoma. The anti-NB1 antibodies can be specifically removed from normal mouse sera by absorption of the sera with homogenized brain tissue of mouse, rat, guinea pig, chicken, and man and by homogenized kidney tissue of mouse and man. The antigen recognized by anti-NB1 naturally occurring autoantibodies, designated mouse brain antigen-2 (MBA-2), is not present on other normal tissues or tumor cell lines tested. MBA-2 is distinct from previously described mouse brain antigens.
The immune system is thought to function in-the detection and elimination of nascent, autochthonous tumors (1, 2) . Tumor cells may express cell surface components absent from normal cells (2, 3) but the crucial issue of how the immune system mounts a destructive response against these components and not against normal cell surface components is unresolved. The maintenance of "immunological tolerance" to self-components may involve the production of autoantibodies which are capable of repressing tissue destructive autoimmunity (4, 5) . The finding of near-normal tumor incidence in congenitally athymic (nude) mice, however, suggests that humoral immunity might also be responsible for immune surveillance against tumor cells (6) . It is of interest, therefore, that antibodies reactive with a variety of tumor cells can be detected in sera of both normal and congenitally athymic mice (7) (8) (9) (10) . The determination of whether the antigens eliciting the production of tumor reactive naturally occurring antibodies (NOA) are tumor specific or normal tissue antigens might help in elucidating the biological role of these antibodies. This paper documents that the cell surface antigen of a neural tumor cell line recognized by NOA in mouse sera is a tissue differentiation antigen present in Cytotoxicity Assays. Two step trypan blue dye exclusion and 51Cr-release cytotoxicity assays were performed as described previously (7, 11) with the exception that cells were washed with 4 ml of BSS-10 prior to the addition of mouse tissue absorbed rabbit complement (RC'). The average percent lysis of NB1 cells due to medium alone was 7.6% and that due to RC' alone (at a 1:4 dilution) was 10.1%. Undiluted Table 2 .
Homogenates of brain tissue of rat, guinea pig, chicken, and man, and homogenates of human kidney tissue removed significant amounts of anti-NB1 NOA from the normal mouse sera.
The anti-NB1 cytotoxic NOA activity was not absorbed by kidney tissue homogenates of rat, guinea pig, or chicken, or by homogenates of liver tissue from any of the species examined.
None of the tissues from any of the species studied reduced the cytotoxic activity of anti-85-72 NOA ( Table 2 ). The removal of cytotoxic anti-NB1 NOA by brain tissue homogenates cannot be attributed to anticomplementary effects of absorption with brain tissue for several reasons: (1) in the two step cytotoxicity assay employed in these studies, target cells were washed thoroughly after exposure to serum and prior to the addition of RC'; (2) control experiments have demonstrated that the cytotoxic activity against NB1 of mouse sera diluted 1: 2 with medium that had been incubated with homogenized brain tissue of either mouse or human origin was not significantly different from that of mouse sera diluted 1: 2 in normal medium (data not given); and (3) the concentration of RC' required to achieve maximal lysis of both NB1 and 85-72 target cells exposed to normal serum is the same (1:4), yet absorption of normal serum with brain tissue homogenates only reduced the cytotoxicity against the NB1 target cells.
NB1 antigen recognized by NOA not detected on other tumor cell lines Normal C3Hf/He serum was absorbed with a variety of tumor cell lines to determine the specificity of the NOA reactive with NB1. With an absorption ratio of 1: 2 (packed cells to serum) NB1 cells completely removed the cytotoxic activity against NB1 cells present in the C3Hf/He serum. In contrast, the anti-NB1 NOA activity in normal C3Hf/He serum was not detectably reduced by the other cell lines, even though NOA cytotoxic for each of these cell lines are present in normal C3Hf/He serum (Table 3) .
DISCUSSION
The results of these studies demonstrate that the NB1 cellsurface antigen recognized by NOA in mouse sera is a normal tissue differentiation antigen present in brain and kidney, but not liver, lung, muscle, spleen, or thymus tissues of mice. This antigen, designated mouse brain antigen-2 (MBA-2) appears to be conserved during phylogeny since it is detected in brain tissue of species as diverse as man and chicken. MBA-2 is distinct from previously described mouse brain antigens. It can be distinguished (i) from mouse brain antigen-1 (MBA-1) (11) since MBA-2 is not expressed in detectable amounts on the mouse neuroblastoma C1300; (ii) from the recently described mammalian glial cell antigen NS-1 (12) by the absence of MBA-2 from the glial cell line G26 and the presence of MBA-2 on chicken brain; (iii) from the antigen recognized by antibodies raised in rabbits against differentiated C1300 cells (13, 14) because MBA-2 is present in mouse kidney tissue; (iv) from both the 0 alloantigen (15) and the NZB autoantigen (16) by the inability to detect MBA-2 on thymus cells; (v) from the plasma cell alloantigen PC-1 (17) because MBA-2 is not present on spleen or liver; and (vi) from the serologically defined Sk alloantigen (18) since MBA-2 is present in brain and kidney of both C3Hf/He and C57BL/6 mice.
Unlike MBA-2, the antigen recognized by NOA on the surface of the lung tumor cell line 85-72 could not be readily detected on normal tissues. This finding suggests that not all NOA reactive with tumor cells are necessarily directed against major tissue antigens. 85-72 has been shown by electron microscopy to express budding type-C viruses.l In view of the recent demonstration of NOA in mouse sera reactive with type-C viruses (19) (20) (21) , it is possible that cytotoxicity against the 85-72 cell line is due to naturally occurring anti-viral antibodies.
Electron microscopic studies of the NB1 cell line did not reveal the presence of budding type-C viruses. Both the in vivo tumor and the in vitro cell line contain intracisternal type-A virus particles. Because of the autoantibody nature of the NOA reactive with the NB1 cell line, it is difficult to ascribe a tumor-destructive role to tumor reactive NOA. NOA in the form of antigenantibody complexes have been postulated to be an important mechanism in the prevention of tissue-destructive autoimmunity (4, 5) . Whether naturally occurring anti-tumor antibodies circulate as free antibody or as antigen-antibody complexes has not been determined. If these antibodies do exist as antigen-antibody complexes, however, then the presence of MBA-2 in the mouse kidney could be readily explained by the known ability of the kidney to sequester antigen-antibody complexes (22, 23) . Furthermore, the presence of MBA-2 in human kidney would then suggest that circulating anti-brain autoantibodies might be readily detected in human sera.
As reported previously, a variety of mouse tumor cell lines are susceptible to lysis by normal mouse sera in the presence of RC' (7). It is apparent from the present study that detailed analysis of the specificity of the antibodies reactive with tumor cell lines offers a promising approach to the identification of a wide array of cell surface components.
